Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
50.10    -0.80 (-1.57%)
Bid:
50.20
Ask:
50.80
Spread: 0.60 (1.195%)
Market Cap: £317.06m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Holding(s) in Company

16 Apr 2009 16:50

RNS Number : 7125Q
Marston's PLC
16 April 2009
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Marston's plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issues to which voting rights are attached

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to the notification obligation:

Lloyds Banking Group plc

4. Full name of shareholder(s) (if different from 3.):

See Section 9

5. Date of the transaction and date on which the threshold is crossed or reached:

15 April 2009

6. Date on which issuer notified:

16 April 2009

7. Threshold(s) that is/are crossed or reached:

Reduction to below 5%

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the Triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Ord 7.375p

4,062,749

4,062,749

7,272,563

2,145,406

1,872,917

2.667%

2.328%

GB00B1JQDM80

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

N/A

Total (A+B)

Number of voting rights

% of voting rights

4,018,323

4.995%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

6,806,997 shares representing 2,008,064 voting rights (2.496%) are under the control of Star Securities Limited, a 50% owned Joint Venture of Uberior Investments plc, a wholly owned subsidiary of Bank of Scotland plc , a wholly owned subsidiary of HBOS plc, a wholly owned subsidiary of Lloyds Banking Group plc (Direct Interests).

4,550,457 Shares representing 1,342,384 voting rights (1.669%) are held by State Street Nominees Ltd. Shares are under the control of Scottish Widows Investment Partnership Ltd, a wholly owned subsidiary of Scottish Widows Group Ltd, a wholly owned subsidiary of Lloyds TSB Bank plc, a wholly owned subsidiary of Lloyds Banking Group plc (Indirect Interests).

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

Notification using the total voting rights figure of

80,450,220

14. Contact name:

Kenny Melville

15. Contact telephone number:

0131 243 8671

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLILFSESSIRLIA
Date   Source Headline
9th Jun 202010:36 amRNSNotice of Results
8th Jun 202011:48 amRNSPublication of Circular and Notice of GM
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
29th May 202010:47 amRNSCOVID-19 Update Results Noteholder Consent Request
22nd May 20204:35 pmRNSPrice Monitoring Extension
22nd May 20201:35 pmRNSMarston’s and Carlsberg UK form JV Partnership
14th May 20207:00 amRNSCOVID-19 Financing and Dividend Update
7th May 202012:57 pmRNSCOVID-19 Update re: Noteholder Consent Request
4th May 202012:12 pmRNSChange to Interim Results Announcement Date
20th Apr 20207:00 amRNSCOVID-19 Update re: securitisation waiver granted
18th Mar 20207:00 amRNSCOVID-19 Update
17th Mar 202012:07 pmRNSSecond Price Monitoring Extn
17th Mar 202012:02 pmRNSPrice Monitoring Extension
3rd Feb 202012:51 pmRNSTotal Voting Rights
27th Jan 202010:19 amRNSResult of AGM
24th Jan 20207:00 amRNSTrading Update
10th Jan 20209:20 amRNSBlock listing Interim Review
2nd Jan 202011:43 amRNSTotal Voting Rights
27th Dec 20197:00 amRNSDirector Declaration
18th Dec 20194:28 pmRNSAnnual Financial Report
12th Dec 20193:52 pmRNSDirector/PDMR Shareholding
27th Nov 20197:00 amRNSPreliminary Results
25th Nov 20197:00 amRNSCompletion of Disposal
21st Nov 20192:52 pmRNSDirectorate Change
4th Nov 20197:00 amRNSDisposal
1st Nov 20192:24 pmRNSTotal Voting Rights
15th Oct 20197:00 amRNSYear End Trading Update
1st Oct 201910:05 amRNSTotal Voting Rights
2nd Sep 20192:15 pmRNSTotal Voting Rights
29th Jul 20197:00 amRNSBoard Changes
24th Jul 20197:00 amRNSTrading Update
10th Jul 201911:15 amRNSBlock listing Interim Review
17th Jun 20193:37 pmRNSDirector/PDMR Shareholding
15th May 20197:00 amRNSInterim results for 26 weeks ended 30 March 2019
4th Mar 201911:51 amRNSTotal Voting Rights
1st Feb 20199:11 amRNSTotal Voting Rights
24th Jan 201910:29 amRNSResult of AGM
23rd Jan 20197:00 amRNSTrading Update for the 16 weeks to 19 January 2019
11th Jan 20198:48 amRNSBlock listing Interim Review
2nd Jan 20192:20 pmRNSTotal Voting Rights
19th Dec 201811:04 amRNSAnnual Financial Report
13th Dec 20183:09 pmRNSDirector/PDMR Shareholding
13th Dec 20183:07 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSPreliminary Results
8th Nov 20188:46 amRNSHolding(s) in Company
6th Nov 20184:19 pmRNSHolding(s) in Company
2nd Nov 20182:39 pmRNSHolding(s) in Company
1st Nov 20183:35 pmRNSHolding(s) in Company
1st Nov 20181:25 pmRNSTotal Voting Rights
12th Oct 20184:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.